Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 18630

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(±)-4-hydroxy Propranolol is an active metabolite of the β-adrenergic receptor antagonist (±)-propranolol (Item No. 23349).1 It is formed from propranolol by the cytochrome P450 (CYP) isoform CYP2D6.2 (±)-4-hydroxy Propranolol decreases tachycardia and vasodepression induced by the β1- and β2-adrenergic receptor agonist isoproterenol (Item No. 15592) in cats (EC50 = 54 µg/kg).1 It increases heart rate in rats depleted of catecholamines by the monocarboxylate transporter 1 (MCT1) and MCT2 inhibitor syrosingopine (Item No. 36402) when administered at doses of 10 and 80 µg/kg. (±)-4-hydroxy Propranolol decreases heart rate, myocardial contractility, and cardiac output in dogs in a dose-dependent manner.3 It also reduces superoxide-induced lipid peroxidation in isolated rat hepatic microsomes (IC50 = 1.1 µM) and prevents superoxide-induced depletion of glutathione (GSH) levels in bovine aortic endothelial cells (BAECs; EC50 = 1.2 µM).4
WARNING This product is not for human or veterinary use.
1. Pharmacology of 4-
2. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers–N-
3. A comparison of the haemodynamic effects of propranolol, 4-
4. Potent antioxidant properties of 4-
Generation of HepG2 cells with high expression of multiple drug-